Open access
Open access
Powered by Google Translator Translator

GI Surgery – Bariatric Surgery

Cohort study: In patients who underwent bariatric surgery, those submitted to gastric bypass were slightly more likely to remain free of obesity-related medications during follow-up compared with those who underwent sleeve gastrectomy.

18 Jan, 2022 | 09:31h | UTC

Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass – JAMA Surgery (link to abstract – $ for full-text)

Commentary: Gastric Bypass Tied to Modest Shift in Need for Comorbidity Meds – MedPage Today (free registration required)

 

Commentary on Twitter

 

ERAS Guidelines for perioperative care in bariatric surgery.

16 Jan, 2022 | 23:21h | UTC

Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update – World Journal of Surgery

Related: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

 

Commentary on Twitter

 

Cohort Study: Patients who achieved weight loss through bariatric surgery may have lower risk for severe Covid-19 compared to patients who did not have surgical intervention for their obesity.

14 Jan, 2022 | 08:32h | UTC

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection – JAMA Surgery

Commentaries:

Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery? – JAMA Surgery

Can weight loss help protect against Covid-19? – CNN

 

RCT: Adjustable intragastric balloon resulted in significant weight loss at 32 weeks, but intolerance caused early removal of the device in 17% of patients, and device-related serious adverse events were observed in 4% of patients.

17 Nov, 2021 | 08:26h | UTC

Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial – The Lancet (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Cohort study: In patients with nonalcoholic steatohepatitis and obesity, bariatric surgery was associated with lower risk of incident major adverse liver outcomes and major adverse cardiovascular events.

12 Nov, 2021 | 10:24h | UTC

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis – JAMA (free for a limited period)

Editorial: Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis – JAMA (free for a limited period)

 

Commentary on Twitter

 

Large observational study suggests sleeve gastrectomy may be safer compared to gastric bypass in patients with severe obesity.

7 Oct, 2021 | 10:26h | UTC

Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity – JAMA Surgery (free for a limited period)

Commentaries:

Compared to What?—Novel Methods to Approach Randomization for Long-term Bariatric Surgery Outcomes – JAMA Surgery (free for a limited period)

Of two common weight loss surgeries, one is safer but less effective – Michigan Medicine

Related:

Different risks and benefits leading to similar costs after sleeve gastrectomy and roux-en-y gastric bypass.

Laparoscopic roux-en-y gastric bypass vs. laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials

Randomized trial: no difference in quality of life and slightly greater weight loss with roux-en-y gastric bypass compared to laparoscopic sleeve gastrectomy at 7 years

Cohort study: comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass

Cohort study: interventions and operations 5 years after bariatric surgery

Cohort study: risk of operative and nonoperative interventions after roux-en-y gastric bypass vs. vertical sleeve gastrectomy

Randomized trial: gastric bypass superior to sleeve gastrectomy for remission of type 2 diabetes

Research: laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass

 

Commentary on Twitter

 

Different risks and benefits leading to similar costs after sleeve gastrectomy and Roux-en-Y gastric bypass.

12 Sep, 2021 | 21:37h | UTC

Commentary: Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass – JAMA Network Open

Original study: Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy – JAMA Network Open

 

Commentary on Twitter

 

AGA clinical practice update on evaluation and management of early complications after bariatric/metabolic surgery.

24 Aug, 2021 | 09:02h | UTC

AGA Clinical Practice Update on Evaluation and Management of Early Complications After Bariatric/Metabolic Surgery: Expert Review – Clinical Gastroenterology and Hepatology

 

Commentary on Twitter

 

Podcast | Bariatric Surgery for the Internist – Patient selection, perioperative management, and post-operative care.

25 May, 2021 | 08:37h | UTC

#275 Bariatric Surgery for the Internist with Dr. Vivian Sanchez – The Curbsiders

 

M-A: Metabolic–bariatric surgery is associated with increased long-term survival in adults with obesity, the effects being more pronounced for people with pre-existing diabetes

11 May, 2021 | 09:11h | UTC

Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants – The Lancet (link to abstract – $ for full-text)

 

RCT: Closure vs. non-closure of mesenteric defects during laparoscopic gastric bypass surgery – In this single-center trial, routine closure of the mesenteric defects in laparoscopic Roux-en-Y gastric bypass with clips was associated with a lower rate of internal herniation

28 Apr, 2021 | 08:04h | UTC

Randomized clinical trial on closure versus non-closure of mesenteric defects during laparoscopic gastric bypass surgery – British Journal of Surgery (link to abstract – $ for full-text)

 

Commentary on Twitter

 

AGA recommends intragastric balloons as an additional weight loss option for obese patients

23 Apr, 2021 | 08:10h | UTC

AGA recommends intragastric balloons as an additional weight loss strategy for obese patients – American Gastroenterological Association

Original article: AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity – Gastroenterology

 

M-A: Portal venous system thrombosis after bariatric surgery

21 Apr, 2021 | 06:16h | UTC

Portal venous system thrombosis after bariatric surgery: A systematic review and meta-analysis – Surgery (link to abstract – $ for full-text)

 

The first modified Delphi consensus statement on sleeve gastrectomy

9 Mar, 2021 | 02:09h | UTC

The first modified Delphi consensus statement on sleeve gastrectomy – Surgical Endoscopy

 

Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials

2 Mar, 2021 | 01:27h | UTC

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS) – British Journal of Surgery

Visual abstract: Merged SLEEVEPASS and SM-BOSS trials

 

Study: Unhealthy alcohol use common after bariatric surgery

26 Feb, 2021 | 08:14h | UTC

Association of Bariatric Surgical Procedures With Changes in Unhealthy Alcohol Use Among US Veterans – JAMA Network Open

Commentaries: Unhealthy Alcohol Use—A Common Iatrogenic Complication of Bariatric Surgery – JAMA Network Open AND Bariatric Surgery May Increase Risk of Unhealthy Alcohol Use – Psychiatric News Alert AND Bariatric Surgery Ups Risk of Alcohol Abuse – Physician’s Weekly

 

Commentary on Twitter

 

10-year follow up of a randomized trial shows metabolic surgery is more effective than conventional medical therapy for the control of type 2 diabetes

26 Jan, 2021 | 00:44h | UTC

Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary: Gastrointestinal surgery can be a ‘cure’ for type 2 diabetes finds new long-term study – King’s College London

 

Stay Updated in Your Specialty

No spam, just news.